Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution

MLA

Emma B Holliday, et al. “Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution.” The Oncologist, vol. 27, Jan. 2022, pp. 40–47. EBSCOhost, https://doi.org/10.1093/oncolo/oyab006.

APA

Emma B Holliday, Van K Morris, Benny Johnson, Cathy Eng, Ethan B Ludmir, Prajnan Das, Bruce D Minsky, Cullen Taniguchi, Grace L Smith, Eugene J Koay, Albert C Koong, Marc E Delclos, John M Skibber, Miguel A Rodriguez-Bigas, Y Nancy You, Brian K Bednarski, Mathew M Tillman, George J Chang, Kristofer Jennings, & Craig A Messick. (2022). Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. The Oncologist, 27, 40–47. https://doi.org/10.1093/oncolo/oyab006

Chicago

Emma B Holliday, Van K Morris, Benny Johnson, Cathy Eng, Ethan B Ludmir, Prajnan Das, Bruce D Minsky, et al. 2022. “Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution.” The Oncologist 27 (January): 40–47. doi:10.1093/oncolo/oyab006.